EUVIMEDEUVIMED entdecken
Crossref

Clonal evolution defines risk stratification for central nervous system leukemia in adult acute lymphoblastic leukemia

Jia Li, Junjie Chen, Qiang Wang, Jiawang Ou, Zicong Huang, Shiyu Deng, Jieping Lin, Zihong Cai, Qifa Liu, HongSheng Zhou

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-06116-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Jia Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Central Nervous System Neoplasms, Clonal Evolution. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Planning Project of Guangdong Province, Clinical Trial Funding of Nanfang Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is well established that central nervous system leukemia (CNSL) is an adverse prognostic factor in acute lymphoblastic leukemia (ALL), yet whether prognostic heterogeneity reside in CNSL is less addressed. Therefore, we aimed to develop potential risk classification for CNSL. We retrospectively analyzed a study in PDT-ALL-2016 pediatric-inspired cohort (N = 494). Flow cytometry (FCM) and next-generation sequencing (NGS) were tested on bone marrow (BM) and cerebrospinal fluid (CSF). The 5-year OS of 437 non-CNSL patients was 62.3% and 33.7% in 57 CNSL patients (P < 0.001). 57 CNSL including 16 primary CNS involvement and 41 CNS relapse patients were divided into 3 groups. The 5-year OS was 48.9% in patients with concordant FCM and NGS between BM and CSF, which were defined as non-clonal evolutionary CNSL, a standard-risk subgroup, while the 5-year OS was 30.2% in patients with discordant FCM or NGS between BM and CSF and isolated CNS relapse (P < 0.05), which were defined as clonal evolutionary CNSL, a high-risk subgroup. Furthermore, the mean times of lumbar punctures to achieve complete remission (CR) in CSF was 4.14 in clonal evolutionary CNSL, comparing to 1.62 in non-clonal evolutionary CNSL (P < 0.05). Based on the evidence of clonal evolution, we develop a risk stratification for CNSL for the first time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaCentral Nervous System NeoplasmsClonal EvolutionHumansMaleFemaleAdultRetrospective StudiesAdolescentMiddle AgedYoung AdultRisk AssessmentHigh-Throughput Nucleotide SequencingAgedPrognosisFlow Cytometry

Stichwörter der Autor:innen

Central nervous system leukemiaClone evolutionNext generation sequenceRisk stratification

Autor:innen und Institutionen

  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. hanson_tcm@126.com.

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Planning Project of Guangdong Province
  • Clinical Trial Funding of Nanfang Hospital
  • Beijing Xisike Clinical Oncology Research Foundation

Zitieren

APA

Li, J., Chen, J., Wang, Q., Ou, J., Huang, Z., Deng, S., Lin, J., Cai, Z., Liu, Q., & Zhou, H. (2024). Clonal evolution defines risk stratification for central nervous system leukemia in adult acute lymphoblastic leukemia. Annals of Hematology. https://doi.org/10.1007/s00277-024-06116-w

Vancouver

Li J, Chen J, Wang Q, Ou J, Huang Z, Deng S, et al. Clonal evolution defines risk stratification for central nervous system leukemia in adult acute lymphoblastic leukemia. Annals of Hematology. 2024. doi:10.1007/s00277-024-06116-w

BibTeX
@article{Li2024,
  author = {Li, Jia and Chen, Junjie and Wang, Qiang and Ou, Jiawang and Huang, Zicong and Deng, Shiyu and Lin, Jieping and Cai, Zihong and Liu, Qifa and Zhou, HongSheng},
  title = {Clonal evolution defines risk stratification for central nervous system leukemia in adult acute lymphoblastic leukemia},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-06116-w}
}
Kostenlos starten →